UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000006100
Receipt No. R000007217
Scientific Title Examination of a new medicine notebook format for patient information sharing
Date of disclosure of the study information 2011/08/02
Last modified on 2015/08/25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Examination of a new medicine notebook format for patient information sharing
Acronym Examination of a new format for patient information sharing
Scientific Title Examination of a new medicine notebook format for patient information sharing
Scientific Title:Acronym Examination of a new format for patient information sharing
Region
Japan

Condition
Condition All diseases
Classification by specialty
Medicine in general Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 In this study, we extract problems and the improvement in the healthcare setting for the purpose of the smooth information sharing between the hospital, community pharmacy, the patient and make the final format.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes We interview it before and after the use of the format analyze the interview date.
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Behavior,custom
Interventions/Control_1 Information sharing.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria * Patient who uses the hospital and community pharmacy of the study enforcement institution more than once a month.
* Patient who receives preparation of drugs in community pharmacy.
* Patient who it was got participation in this study.
* Patient who there is ability for agreement, and can follow an observance matter during a trial entry.
Key exclusion criteria Under 20 years.
Target sample size 20

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Tomoka OSUMI
Organization Chiba Pharmaceutical Association
Division name Drug Information Center
Zip code
Address 9-2 Tonyacho, Chuo-ku, Chiba-shi, Chiba
TEL 043-247-4401
Email drug-info@c-yaku.or.jp

Public contact
Name of contact person
1st name
Middle name
Last name Tomoka OSUMI
Organization Chiba Pharmaceutical Association
Division name Drug Information Center
Zip code
Address 9-2 Tonyacho, Chuo-ku, Chiba-shi, Chiba
TEL 043-247-4401
Homepage URL
Email drug-info@c-yaku.or.jp

Sponsor
Institute Tomoka OSUMI
Institute
Department

Funding Source
Organization Chiba Pharmaceutical Association
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2011 Year 08 Month 02 Day

Related information
URL releasing protocol
Publication of results Published

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results In our study, work physician one person after use of the cooperation format, pharmacy pharmacist three people, was carried out interviews in 6 patients.
It analyzes the interview contents were improved to a more appropriate format.
Physicians, pharmacists and patients to take advantage of this format, we had to share a treatment and drug information.
Further, as a problem of the format used in the study, was also obtained as a result of the amount of information as described in the paper is limited.
This research results in the medical workers - as an information sharing tool between patients, was verified and correct cooperation format. However, since the sample size is small, there is a possibility that the deviation occurs. The cooperation format that was created from the present study the future that plays what role in the region, there is a need to follow-up.
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2011 Year 06 Month 14 Day
Date of IRB
Anticipated trial start date
2011 Year 07 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2011 Year 08 Month 02 Day
Last modified on
2015 Year 08 Month 25 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007217

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.